Cynapsus Therapeutics Inc  

(Public, CVE:CTH)   Watch this stock  
Find more results for CTH
Nov 27 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.38 - 1.51
Open     -
Vol / Avg. 0.00/303,419.00
Mkt cap 98.66M
P/E     -
Div/yield     -
EPS -0.14
Shares 79.56M
Beta 0.81
Inst. own     -
Nov 9, 2015
Q3 2015 Results Add to calendar
Nov 9, 2015
Q3 2015 Cynapsus Therapeutics Inc Earnings Release (Estimated) Add to calendar
Sep 10, 2015
Cynapsus Therapeutics Inc at BioCentury NewsMakers in the Biotech Industry Conference
Sep 9, 2015
Cynapsus Therapeutics Inc at Rodman & Renshaw Global Investment Conference
Aug 14, 2015
Q2 2015 Cynapsus Therapeutics Inc Earnings Release
Aug 7, 2015
Q2 2015 Results

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -58.07% -99.71%
Return on average equity -60.84% -134.69%
Employees 6 -
CDP Score - -


828 Richmond St W
+1-416-7032449 (Phone)
+1-416-7038752 (Fax)

Website links


Cynapsus Therapeutics Inc. is a Canada-based clinical-stage, specialty pharmaceutical company. The Company is engaged in developing a sublingual thin filmstrip to manage OFF episodes associated with Parkinson’s disease. The Company's drug candidate is APL-130277, which is a reformulation of apomorphine. The drug is an approved acute drug in the United States, Europe, Japan and other countries. The Company completed a CTH-105 Phase II clinical trial comprising approximately 16 people with Parkinson's disease.

Officers and directors

Rochelle E. Stenzler Independent Chairman of the Board
Age: 52
Anthony Giovinazzo President, Chief Executive Officer, Director
Andrew Williams Chief Financial Officer, Chief Operating Officer
Thierry Bilbault Executive Vice President - Chemistry, Manufacturing and Controls, Chief Scientific Officer
Jordan Dubow M.D. Vice President - Medical Affairs
Albert Agro Chief Medical Officer
Tomer Gold Independent Director
Ronald G. Hosking Independent Director
Age: 70
Tamar D. Howson Independent Director
Age: 66
Nan Hutchinson Independent Director